Menu
← Oncology Approval Tracker
FDA DECISION ·
Imbruvica oral suspension
ibrutinib · Pharmacyclics / AbbVie
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Oral suspension for adults and children age one or older with chronic GVHD after failure of at least one systemic therapy line.
LAMPGEN ANALYSIS
Why it matters
The liquid formulation provides a labeled option for younger patients and patients who need liquid administration.
What research teams should watch
Check formulation strength, administration device, and age- and body-size-based dosing instructions.
PRIMARY RECORDS